rdf:type |
|
lifeskim:mentions |
umls-concept:C0003241,
umls-concept:C0019691,
umls-concept:C0019704,
umls-concept:C0042210,
umls-concept:C0085432,
umls-concept:C0205263,
umls-concept:C0442040,
umls-concept:C1167622,
umls-concept:C1171370,
umls-concept:C1257890,
umls-concept:C1513895
|
pubmed:issue |
6
|
pubmed:dateCreated |
1997-2-18
|
pubmed:abstractText |
Salivary binding antibodies induced by candidate human immunodeficiency virus type 1 (HIV-1) vaccines in healthy, HIV-1 uninfected volunteers were assessed in a clinical trial evaluating intramuscularly injected HIV-1MN recombinant gp120 (rgp120) vaccine alone or with HIV-1IIIB rgp120 vaccine. The two rgp120 vaccines induced envelope glycoprotein-specific immunoglobulin G (IgG) and IgA antibodies in whole saliva and serum.
|
pubmed:grant |
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/8914773-1346285,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8914773-1466996,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8914773-1517967,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8914773-1539467,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8914773-1602554,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8914773-1609280,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8914773-1672924,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8914773-1845126,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8914773-2190095,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8914773-2204698,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8914773-3277513,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8914773-3531561,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8914773-7474077,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8914773-7625118,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8914773-7658082,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8914773-7751656,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8914773-7814455,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8914773-7913731,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8914773-7986587,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8914773-8028613,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8914773-8100910,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8914773-8157978,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8914773-8369168,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8914773-8441249,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8914773-8493576,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8914773-8678387
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
1071-412X
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
3
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
769-73
|
pubmed:dateRevised |
2009-11-18
|
pubmed:meshHeading |
pubmed-meshheading:8914773-AIDS Vaccines,
pubmed-meshheading:8914773-Binding, Competitive,
pubmed-meshheading:8914773-Female,
pubmed-meshheading:8914773-HIV Antibodies,
pubmed-meshheading:8914773-HIV Envelope Protein gp120,
pubmed-meshheading:8914773-Humans,
pubmed-meshheading:8914773-Injections, Intramuscular,
pubmed-meshheading:8914773-Male,
pubmed-meshheading:8914773-Saliva,
pubmed-meshheading:8914773-Vaccines, Synthetic
|
pubmed:year |
1996
|
pubmed:articleTitle |
Salivary binding antibodies induced by human immunodeficiency virus type 1 recombinant gp120 vaccine. The NIAID AIDS Vaccine Evaluation Group.
|
pubmed:affiliation |
Department of Internal Medicine, Saint Louis University School of Medicine, Missouri, USA.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, U.S. Gov't, P.H.S.,
Controlled Clinical Trial
|